HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vincent A Miller Selected Research

Vincent A Miller Research Topics

Disease

179Neoplasms (Cancer)
10/2021 - 02/2002
68Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 02/2002
44Lung Neoplasms (Lung Cancer)
12/2020 - 01/2005
34Adenocarcinoma of Lung
01/2018 - 01/2005
22Adenocarcinoma
01/2021 - 03/2004
20Carcinoma (Carcinomatosis)
01/2020 - 07/2002
19Breast Neoplasms (Breast Cancer)
11/2020 - 02/2002
15Neoplasm Metastasis (Metastasis)
03/2021 - 11/2002
14Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 06/2003
9Melanoma (Melanoma, Malignant)
01/2019 - 07/2012
7Microsatellite Instability
01/2020 - 11/2016
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 02/2011
7Disease Progression
02/2016 - 05/2005
6Exanthema (Rash)
01/2022 - 09/2005
6Sarcoma (Soft Tissue Sarcoma)
01/2018 - 12/2012
5Diarrhea
01/2022 - 09/2005
5Triple Negative Breast Neoplasms
02/2019 - 02/2014
5Fatigue
11/2017 - 05/2005
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 02/2003
4Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 08/2015
4Squamous Cell Carcinoma of Head and Neck
10/2019 - 01/2013
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2017
3Hematologic Neoplasms (Hematological Malignancy)
12/2018 - 01/2016
3Hypersensitivity (Allergy)
01/2018 - 02/2008
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2017 - 05/2005
3Inflammatory Breast Neoplasms
11/2015 - 02/2014
3Colonic Neoplasms (Colon Cancer)
01/2015 - 07/2012
3Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
05/2011 - 11/2004
3Stomatitis
08/2007 - 06/2003
2Glioma (Gliomas)
01/2020 - 11/2016
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 12/2015
2Testicular Neoplasms (Testicular Cancer)
01/2020 - 01/2019
2Lymphoma (Lymphomas)
01/2018 - 10/2011

Drug/Important Bio-Agent (IBA)

58ErbB Receptors (EGF Receptor)IBA
01/2018 - 06/2003
42Tyrosine Kinase InhibitorsIBA
01/2021 - 02/2003
40Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2017 - 01/2005
39Gefitinib (Iressa)FDA Link
01/2022 - 06/2003
38DNA (Deoxyribonucleic Acid)IBA
01/2020 - 11/2008
30Phosphotransferases (Kinase)IBA
01/2020 - 01/2005
27Biomarkers (Surrogate Marker)IBA
12/2020 - 03/2011
18Formaldehyde (Formol)FDA Link
01/2020 - 05/2013
18ParaffinIBA
01/2020 - 05/2013
17CrizotinibIBA
10/2019 - 09/2012
17Proteins (Proteins, Gene)FDA Link
01/2019 - 02/2002
16Immune Checkpoint InhibitorsIBA
10/2021 - 03/2016
12Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019 - 11/2003
12Anaplastic Lymphoma KinaseIBA
01/2018 - 12/2012
10Circulating Tumor DNAIBA
10/2020 - 01/2017
10Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2019 - 04/2010
9EverolimusFDA Link
01/2021 - 08/2007
9Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020 - 01/2016
8RNA (Ribonucleic Acid)IBA
01/2020 - 12/2013
8AfatinibIBA
11/2017 - 05/2012
8Paclitaxel (Taxol)FDA LinkGeneric
06/2012 - 06/2003
7Estrogen ReceptorsIBA
11/2020 - 12/2013
7TOR Serine-Threonine KinasesIBA
09/2017 - 10/2010
6Docetaxel (Taxotere)FDA Link
07/2007 - 02/2003
5Trastuzumab (Herceptin)FDA Link
11/2019 - 02/2002
5LigandsIBA
12/2018 - 07/2012
4tyrosine receptor (receptor, tyrosine)IBA
01/2020 - 01/2012
4Monoclonal AntibodiesIBA
12/2019 - 02/2002
4Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2019 - 05/2014
4MTOR InhibitorsIBA
01/2019 - 01/2013
4dabrafenibIBA
01/2018 - 01/2015
4Cetuximab (Erbitux)FDA Link
11/2017 - 04/2011
4Mitogen-Activated Protein KinasesIBA
11/2016 - 04/2010
4Carboplatin (JM8)FDA LinkGeneric
06/2012 - 06/2003
3AlbuminsIBA
03/2021 - 02/2008
3PlatinumIBA
12/2020 - 07/2010
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020 - 05/2014
3SolventsIBA
12/2019 - 11/2011
3Codon (Codons)IBA
12/2019 - 09/2008
3osimertinibIBA
12/2019 - 01/2017
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2019 - 05/2014
3Cytotoxins (Cytolysins)IBA
01/2019 - 09/2003
3Calcibiotic Root Canal SealerIBA
01/2018 - 01/2016
3trametinibIBA
01/2018 - 01/2015
3Proto-Oncogene Proteins c-metIBA
01/2017 - 01/2016
3Sorafenib (BAY 43-9006)FDA Link
10/2016 - 01/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2016 - 08/2007
3alectinibIBA
01/2016 - 12/2014
3Threonine (L-Threonine)FDA Link
11/2008 - 03/2005
2palbociclibIBA
11/2020 - 01/2017
2HM781-36BIBA
03/2020 - 10/2019
2Tumor Biomarkers (Tumor Markers)IBA
12/2019 - 11/2004
2Estrogen Receptor Modulators (Antiestrogen)IBA
01/2019 - 08/2017
2Heme (Haem)IBA
12/2018 - 01/2018
2Cell-Free Nucleic AcidsIBA
11/2018 - 01/2018
2Cyclin-Dependent Kinase Inhibitor p15IBA
10/2018 - 11/2016
2Cyclin-Dependent Kinase Inhibitor p16IBA
10/2018 - 11/2016
2temsirolimusFDA Link
01/2018 - 01/2014
2Sirolimus (Rapamycin)FDA Link
01/2018 - 11/2016

Therapy/Procedure

110Therapeutics
01/2022 - 03/2005
40Drug Therapy (Chemotherapy)
12/2020 - 02/2002
10Immunotherapy
01/2021 - 09/2004
7Ligation
01/2017 - 01/2014
5Radiotherapy
01/2017 - 07/2002
4Precision Medicine
03/2021 - 05/2014
3Aftercare (After-Treatment)
01/2017 - 03/2008
3Neoadjuvant Therapy
03/2016 - 02/2014